Adverse events after vaccine administration in cats: 2,560 Cases (2002-2005)

Journal of the American Veterinary Medical Association

Volumn 231, Issue 1, 2007, Pages 94-100

  Moore, George E ^a   DeSantis Kerr, Andrea C ^a   Guptill, Lynn F ^a   Glickman, Nita W ^a   Lewis, Hugh B ^b   Glickman, Lawrence T ^a  

^a PURDUE UNIVERSITY   (United States)

^b Banfield Pet Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANIMAL; ANIMAL DISEASE; ARTICLE; BODY WEIGHT; CASTRATION; CAT; CAT DISEASE; COHORT ANALYSIS; DRUG SURVEILLANCE PROGRAM; FEMALE; IMMUNOLOGY; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; PHYSIOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VACCINATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; ANIMALS; BODY WEIGHT; CASTRATION; CAT DISEASES; CATS; COHORT STUDIES; FEMALE; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; VACCINATION;

ANIMALIA;

EID: 34347324043     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.231.1.94     Document Type: Article

References (28)

1. Varricchio F, Iskander J, Destefano F, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004;23:287-294.
2. Meyer EK. Vaccine-associated adverse events. Vet Clin North Am Small Anim Pract 2001;31:493-514.
3. Starr RM. Reaction rate in cats vaccinated with a new controlled-titer feline panleukopenia-rhinotracheitis-calicivirus-Chlamydia psittaci vaccine. Cornell Vet 1993;83:311-323.
4. Kass PH, Barnes WG Jr, Spangler WL, et al. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 1993;203:396-405.
5. Coyne MJ, Reeves NCP, Rosen DK. Estimated prevalence of injection-site sarcomas in cats during 1992. J Am Vet Med Assoc 1997;210:249-251.
6. Gobar GM, Kass PH. World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in cats. J Am Vet Med Assoc 2002;220:1477-1482.
7. Chen RT, DeStefano F, Davis RL, et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ 2000;78:186-194.
8. Verstraeten T, DeStefano F, Chen RT, et al. Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines. Expert Rev Vaccines 2003;2:21-29.
9. Moore GE, Guptill LF, Ward MP, et al. Adverse events diagnosed within 3 days of vaccine administration in pet dogs. J Am Vet Med Assoc 2005;227:1102-1108.
10. Gaskell RM, Gettinby G, Graham SJ, et al. Veterinary Products Committee working group report on feline and canine vaccination. Vet Rec 2002;150:126-134.
11. Povey RC, Carman PS. Risks of vaccination. In: Pastoret PP, ed. Veterinary vaccinology. New York: Elsevier, 1997;546-551.
12. Ohmori K, Masuda K, Maeda S, et al. IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination. Vet Immunol Immunopathol 2005;104:249-256.
13. Frana TS, Elsken LA, Karli SA. Summary of adverse event reports for veterinary biologic products received by the USDA from 1999 through 2005. J Am Vet Med Assoc 2006;229:1100-1102.
14. Schultze AE, Frank LA, Hahn KA. Repeated physical and cytologic characterizations of subcutaneous postvaccinal reactions in cats. Am J Vet Res 1997;58:719-724.
15. Carroll EE, Dubielzig RR, Schultz RD. Cats differ from mink and ferrets in their response to commercial vaccines: a histologic comparison of early vaccine reactions. Vet Pathol 2002;39:216-227.
16. Tizard I. Veterinary immunology: an introduction. 7th ed. Philadelphia: WB Saunders Co, 2004;247-259.
17. Roth JA. Mechanistic bases for adverse vaccine reactions and vaccine failures. Adv Vet Med 1999;41:681-700.
18. Richards JR, Elston TH, Ford RB, et al. The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel Report. J Am Vet Med Assoc 2006;229:1405-1441.
19. Kass PH, Barnes WG Jr, Spangler WL, et al. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 1993;203:396-405.
20. Nguyen Van N, Taglinger K, Helps CR, et al. Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR. Vet Immunol Immunopathol 2006;113:404-414.
21. Vaccine-Associated Feline Sarcoma Task Force. The current understanding and management of vaccine-associated sarcomas in cats. J Am Vet Med Assoc 2005;226:1821-1842.
22. HogenEsch H, Dunham AD, Scott-Moncrieff C, et al. Effect of vaccination on serum concentrations of total and antigen-specific immunoglobulin E in dogs. Am J Vet Res 2002;63:611-616.
23. Verthelyi D. Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 2001;1:983-993.
24. Olson PN, Mulnix JA, Nett TM. Concentrations of luteinizing hormone and follicle-stimulating hormone in the serum of sexually intact and neutered dogs. Am J Vet Res 1992;53:762-766.
25. Kim MS, Chae HJ, Shin TY, et al. Estrogen regulates cytokine release in human mast cells. Immunopharmacol Immunotoxicol 2001;23:495-504.
26. Page ST, Plymate SR, Bremner WJ, et al. Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites. Am J Physiol Endocrinol Metab 2006;290:E856-E863.
27. Johnson AB, Sohrabji F. Estrogen's effects on central and circulating immune cells vary with reproductive age. Neurobiol Aging 2005;26:1365-1374.
28. Radford AD, Bennett M, McArdle F, et al. The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures. Vaccine 1997;15:1451-1458.